Bayer | BAYN - Ebitda


Bayer reported EUR2.14B in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Air Liquide EUR 4.22B 399.7M Jun/2026
Akzo Nobel EUR 398M 53M Jun/2026
Alcon AG USD 795M 478M Mar/2026
Amarin USD 12.54M 28.57M Jun/2025
Arkema EUR 390.9M 108.2M Jun/2026
AstraZeneca USD 5.16B 510M Jun/2026
BASF EUR 2.45B 93M Jun/2026
Bayer EUR 2.14B 2.31B Jun/2026
Beiersdorf EUR 984M 147M Jun/2025
Corteva USD 1.44B 992M Mar/2026
Covestro EUR 117M 125M Dec/2025
Essilor EUR 4.34B 1.25B Jun/2026
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Genmab DKK 186M 291M Dec/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Linde USD 3.44B 59M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Novartis USD 6.48B 1.19B Jun/2026
Nutrien USD 2.43B 1.33B Jun/2026
Philips EUR 910M 343M Jun/2026
PPG Industries USD 780M 70M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 3.69B 375M Jun/2026
SAP EUR 3.36B 192M Jun/2026
Solvay EUR 187M 32M Jun/2026
UCB EUR 1.6B 570M Dec/2025
Umicore EUR 577M 163M Jun/2026
Vinci EUR 6.4B 1.42B Jun/2026